Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies

The DOCUMENT multicenter trial in the United States validated the performance of an epigenetic test as an independent predictor of prostate cancer risk to guide decision making for repeat biopsy. Confirming an increased negative predictive value could help avoid unnecessary repeat biopsies. We evalu...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of urology Vol. 192; no. 4; p. 1081
Main Authors:	Partin, Alan W, Van Neste, Leander, Klein, Eric A, Marks, Leonard S, Gee, Jason R, Troyer, Dean A, Rieger-Christ, Kimberly, Jones, J Stephen, Magi-Galluzzi, Cristina, Mangold, Leslie A, Trock, Bruce J, Lance, Raymond S, Bigley, Joseph W, Van Criekinge, Wim, Epstein, Jonathan I
Format:	Journal Article
Language:	English
Published:	United States 01.10.2014
Subjects:	Biopsy - methods DNA Methylation DNA, Neoplasm - genetics Epigenesis, Genetic Epigenomics - methods Follow-Up Studies Genes, APC Glutathione S-Transferase pi - biosynthesis Glutathione S-Transferase pi - genetics Humans Male Polymerase Chain Reaction Predictive Value of Tests Prognosis Prostate - metabolism Prostate - pathology Prostatic Neoplasms - genetics Prostatic Neoplasms - metabolism Prostatic Neoplasms - pathology Tumor Suppressor Proteins - biosynthesis Tumor Suppressor Proteins - genetics Unnecessary Procedures - utilization biopsy epigenomics prostate methylation prostatic neoplasms
ISSN:	1527-3792, 1527-3792
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!